Dr Faduola Dr. Paul Faduola, the Chief Executive Officer (CEO) of Androcare Fertility Centre and Oncogenomics is a medical ...

CALIFORNIA, CA, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- The global genetic testing market is anticipated to ...

A new, rapid testing method will greatly help the diagnosis of rare diseases in babies and children, according to research to ...

The liquid biopsy market is emerging as a revolutionary force in the field of medical diagnostics and oncology. Liquid biopsy refers to a non-invasive technique that analyzes biomarkers, such as ...

A new, rapid testing method will greatly help the diagnosis of rare diseases in babies and children, according to research ...

GC Genome expands cancer diagnostics from 6 to 20 types, targets Japan and U.S. GC Genome aims to increase cancer testing ...

Early Detection Of Preeclampsia May Change A Century Old Treatment Framework. In general, preeclampsia presents at 20 weeks ...

Genetic testing is transforming preventive healthcare by revealing hidden disease risks and empowering individuals—especially women—to make informed choices ...

Studies have shown that non-invasive prenatal monitoring techniques ... In most cases, this diagnosis does not affect when, where or how a baby is delivered." "With appropriate follow-up and ...

Non-Invasive Prenatal Testing (NIPT ... Dr Pradhan cautions: “NIPT is a screening tool, not a diagnosis. Always pair it with ultrasounds and medical advice.” ALSO READ: Is Using a Mixer ...

PEARL uses cfDNA analysis for early, non-invasive preeclampsia detection It ... low-income countries Preeclampsia risk prediction from prenatal cell-free DNA screening Go to source).

The only alternative until now has been non-invasive prenatal testing (NIPT), but it can ... Chosen as the cover story of the global journal Prenatal Diagnosis last August, the study involved 18 cases ...